Completed PHASE4 INTERVENTIONAL 3-arm NCT00396747

A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study

Phase IV Study of Early RA: a Randomized Magnetic Resonance Imaging Study Comparing the Effects of Methotrexate Alone or in Combination With Infliximab or Intravenous Pulse Methylprednisolone

Sponsor: Université Catholique de Louvain

Conditions Rheumatoid Arthritis

Interventions Infliximab, methylprednisolone, methotrexate Methotrexate Methotrexate + Infliximab Methotrexate + Methylprednisolone

Updated 5 times since 2017 Last updated: Oct 18, 2007 Started: Jun 30, 2003 Completion: Sep 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Rheumatoid Arthritis and is currently completed. Université Catholique de Louvain leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Université Catholique de Louvain

Data source: Université Catholique de Louvain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium